Pluvicto 1 000 MBq/mL solution for injection/infusion, Lutetium (177Lu) rhPSMA-10.1 injection
BET-PSMA-001
Phase 1 small_molecule active
Quick answer
Pluvicto 1 000 MBq/mL solution for injection/infusion, Lutetium (177Lu) rhPSMA-10.1 injection for PSMA-positive non-curative metastatic castration-resistant prostate cancer is a Phase 1 program (small_molecule) at Blue Earth Diagnostics Ireland Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Blue Earth Diagnostics Ireland Ltd
- Indication
- PSMA-positive non-curative metastatic castration-resistant prostate cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active